Aging with HIV: an overview of an urban cohort in Rio de Janeiro (Brazil) across decades of life
The introduction of highly active antiretroviral therapy during the 1990s was crucial to the decline in the rates of morbidity and death related to the acquired immunodeficiency syndrome (AIDS) and turned human immunodeficiency virus (HIV) infection into a chronic condition. Consequently, the HIV/AIDS population is becoming older. The aim of this study was to describe the immunological, clinical and comorbidity profile of an urban cohort of patients with HIV/AIDS followed up at Instituto de Pesquisa Clinica Evandro Chagas, Oswaldo Cruz Foundation in Rio de Janeiro, Brazil. Retrospective data from 2307 patients during January 1st, 2008 and December 31st, 2008 were collected. For continuous variables, Cuzick's non-parametric test was used. For categorical variables, the Cochran-Armitage non-parametric test for tendency was used. For all tests, the threshold for statistical significance was set at 5%. In 2008, 1023 (44.3%), 823 (35.7%), 352 (15.3%) and 109 (4.7%) were aged 18-39, 40-49, 50-59 and >60 years-old, respectively. Older and elderly patients (>40 years) were more likely to have viral suppression than younger patients (18-39 years) (p 0.001). No significant difference in the latest CD4+ T lymphocyte count in the different age strata was observed, although elderly patients (> 50 years) had lower CD4+ T lymphocyte nadir (p 0.02). The number of comorbidities increased with age and the same pattern was observed for the majority of the comorbidities, including diabetes mellitus, dyslipidemia, hypertension, cardiovascular diseases, erectile dysfunction, HCV, renal dysfunction and also for non-AIDSrelated cancers (p 0.001). With the survival increase associated to successful antiretroviral therapy and with the increasing new infections among elderly group, the burden associated to the diagnosis and treatment of the non-AIDS related HIV comorbidities will grow. Longitudinal studies on the impact of aging on the HIV/AIDS population are still necessary, especially in resource-limited countries.
Main Authors: | , , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Brazilian Society of Infectious Diseases
2013
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702013000300004 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S1413-86702013000300004 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S1413-867020130003000042013-06-13Aging with HIV: an overview of an urban cohort in Rio de Janeiro (Brazil) across decades of lifeTorres,Thiago SilvaCardoso,Sandra WagnerVelasque,Luciane de SouzaMarins,Luana Monteiro SpindolaOliveira,Marília Santini deVeloso,Valdilea GonçalvesGrinsztejn,Beatriz HIV AIDS Aging Elderly Brazil Comorbidity HAART The introduction of highly active antiretroviral therapy during the 1990s was crucial to the decline in the rates of morbidity and death related to the acquired immunodeficiency syndrome (AIDS) and turned human immunodeficiency virus (HIV) infection into a chronic condition. Consequently, the HIV/AIDS population is becoming older. The aim of this study was to describe the immunological, clinical and comorbidity profile of an urban cohort of patients with HIV/AIDS followed up at Instituto de Pesquisa Clinica Evandro Chagas, Oswaldo Cruz Foundation in Rio de Janeiro, Brazil. Retrospective data from 2307 patients during January 1st, 2008 and December 31st, 2008 were collected. For continuous variables, Cuzick's non-parametric test was used. For categorical variables, the Cochran-Armitage non-parametric test for tendency was used. For all tests, the threshold for statistical significance was set at 5%. In 2008, 1023 (44.3%), 823 (35.7%), 352 (15.3%) and 109 (4.7%) were aged 18-39, 40-49, 50-59 and >60 years-old, respectively. Older and elderly patients (>40 years) were more likely to have viral suppression than younger patients (18-39 years) (p 0.001). No significant difference in the latest CD4+ T lymphocyte count in the different age strata was observed, although elderly patients (> 50 years) had lower CD4+ T lymphocyte nadir (p 0.02). The number of comorbidities increased with age and the same pattern was observed for the majority of the comorbidities, including diabetes mellitus, dyslipidemia, hypertension, cardiovascular diseases, erectile dysfunction, HCV, renal dysfunction and also for non-AIDSrelated cancers (p 0.001). With the survival increase associated to successful antiretroviral therapy and with the increasing new infections among elderly group, the burden associated to the diagnosis and treatment of the non-AIDS related HIV comorbidities will grow. Longitudinal studies on the impact of aging on the HIV/AIDS population are still necessary, especially in resource-limited countries.info:eu-repo/semantics/openAccessBrazilian Society of Infectious DiseasesBrazilian Journal of Infectious Diseases v.17 n.3 20132013-06-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702013000300004en10.1016/j.bjid.2012.10.024 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Torres,Thiago Silva Cardoso,Sandra Wagner Velasque,Luciane de Souza Marins,Luana Monteiro Spindola Oliveira,Marília Santini de Veloso,Valdilea Gonçalves Grinsztejn,Beatriz |
spellingShingle |
Torres,Thiago Silva Cardoso,Sandra Wagner Velasque,Luciane de Souza Marins,Luana Monteiro Spindola Oliveira,Marília Santini de Veloso,Valdilea Gonçalves Grinsztejn,Beatriz Aging with HIV: an overview of an urban cohort in Rio de Janeiro (Brazil) across decades of life |
author_facet |
Torres,Thiago Silva Cardoso,Sandra Wagner Velasque,Luciane de Souza Marins,Luana Monteiro Spindola Oliveira,Marília Santini de Veloso,Valdilea Gonçalves Grinsztejn,Beatriz |
author_sort |
Torres,Thiago Silva |
title |
Aging with HIV: an overview of an urban cohort in Rio de Janeiro (Brazil) across decades of life |
title_short |
Aging with HIV: an overview of an urban cohort in Rio de Janeiro (Brazil) across decades of life |
title_full |
Aging with HIV: an overview of an urban cohort in Rio de Janeiro (Brazil) across decades of life |
title_fullStr |
Aging with HIV: an overview of an urban cohort in Rio de Janeiro (Brazil) across decades of life |
title_full_unstemmed |
Aging with HIV: an overview of an urban cohort in Rio de Janeiro (Brazil) across decades of life |
title_sort |
aging with hiv: an overview of an urban cohort in rio de janeiro (brazil) across decades of life |
description |
The introduction of highly active antiretroviral therapy during the 1990s was crucial to the decline in the rates of morbidity and death related to the acquired immunodeficiency syndrome (AIDS) and turned human immunodeficiency virus (HIV) infection into a chronic condition. Consequently, the HIV/AIDS population is becoming older. The aim of this study was to describe the immunological, clinical and comorbidity profile of an urban cohort of patients with HIV/AIDS followed up at Instituto de Pesquisa Clinica Evandro Chagas, Oswaldo Cruz Foundation in Rio de Janeiro, Brazil. Retrospective data from 2307 patients during January 1st, 2008 and December 31st, 2008 were collected. For continuous variables, Cuzick's non-parametric test was used. For categorical variables, the Cochran-Armitage non-parametric test for tendency was used. For all tests, the threshold for statistical significance was set at 5%. In 2008, 1023 (44.3%), 823 (35.7%), 352 (15.3%) and 109 (4.7%) were aged 18-39, 40-49, 50-59 and >60 years-old, respectively. Older and elderly patients (>40 years) were more likely to have viral suppression than younger patients (18-39 years) (p 0.001). No significant difference in the latest CD4+ T lymphocyte count in the different age strata was observed, although elderly patients (> 50 years) had lower CD4+ T lymphocyte nadir (p 0.02). The number of comorbidities increased with age and the same pattern was observed for the majority of the comorbidities, including diabetes mellitus, dyslipidemia, hypertension, cardiovascular diseases, erectile dysfunction, HCV, renal dysfunction and also for non-AIDSrelated cancers (p 0.001). With the survival increase associated to successful antiretroviral therapy and with the increasing new infections among elderly group, the burden associated to the diagnosis and treatment of the non-AIDS related HIV comorbidities will grow. Longitudinal studies on the impact of aging on the HIV/AIDS population are still necessary, especially in resource-limited countries. |
publisher |
Brazilian Society of Infectious Diseases |
publishDate |
2013 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702013000300004 |
work_keys_str_mv |
AT torresthiagosilva agingwithhivanoverviewofanurbancohortinriodejaneirobrazilacrossdecadesoflife AT cardososandrawagner agingwithhivanoverviewofanurbancohortinriodejaneirobrazilacrossdecadesoflife AT velasquelucianedesouza agingwithhivanoverviewofanurbancohortinriodejaneirobrazilacrossdecadesoflife AT marinsluanamonteirospindola agingwithhivanoverviewofanurbancohortinriodejaneirobrazilacrossdecadesoflife AT oliveiramariliasantinide agingwithhivanoverviewofanurbancohortinriodejaneirobrazilacrossdecadesoflife AT velosovaldileagoncalves agingwithhivanoverviewofanurbancohortinriodejaneirobrazilacrossdecadesoflife AT grinsztejnbeatriz agingwithhivanoverviewofanurbancohortinriodejaneirobrazilacrossdecadesoflife |
_version_ |
1756416467442597888 |